Document Detail


Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma.
MedLine Citation:
PMID:  22977617     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The prognosis for patients with large-cell neuroendocrine carcinoma (LCNEC) of the lung is extremely poor, and an optimal treatment has not yet been established. It has been recently reported that molecular-targeted therapies, such as tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), are effective in patients with lung carcinoma. In efforts to improve the prognosis of patients with LCNEC, we analyzed gene expression, gene mutations and immunohistochemical (IHC) expression of known molecular targets in LCNECs, and compared the expression to that of lung adenocarcinomas (ACs). Thirteen patients with primary LCNEC and 14 patients with AC were analyzed. We evaluated IHC expression for c-KIT, human epidermal growth factor receptor type 2 (HER2) and vascular endothelial growth factor (VEGF), gene mutations for EGFR, K-ras and c-kit, and gene expression using fluorescence in situ hybridization for EGFR. In cases with LCNEC, the IHC expression of c-KIT, HER2 and VEGF was 76.9, 30.8 and 100%, respectively. There was a significant difference in the IHC expression of c-KIT and HER2 between the LCNEC and AC cases. Two cases of LCNEC had overexpression of HER2, and the frequency of EGFR gene mutations was higher in the the AC group, with only a single EGFR mutation (exon 18) identified in the LCNEC group. Although LCNEC had a higher rate of expression of c-KIT by IHC, no c-kit gene mutations were found. These findings suggest a potential role for anti-VEGF-, anti-c-KIT- and possibly anti-HER2-targeted agents in the treatment of LCNEC.
Authors:
Akira Iyoda; William D Travis; Inderpal S Sarkaria; Shi-Xu Jiang; Hideki Amano; Yuichi Sato; Makoto Saegusa; Valerie W Rusch; Yukitoshi Satoh
Related Documents :
24947337 - Stress-induced expression of nicotine2-locus genes and their homologs encoding ethylene...
25315507 - Genome modification by crispr/cas9.
24875477 - Cooperative gene regulation by microrna pairs and their identification using a computat...
23702847 - Epigenetic mechanisms in penile carcinoma.
1565097 - Molecular analysis of carbohydrate antigen-induced monoclonal igm anti-igg antibodies (...
11874907 - Onset of the segmentation clock in the chick embryo: evidence for oscillations in the s...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-24
Journal Detail:
Title:  Experimental and therapeutic medicine     Volume:  2     ISSN:  1792-1015     ISO Abbreviation:  Exp Ther Med     Publication Date:  2011 11 
Date Detail:
Created Date:  2012-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531947     Medline TA:  Exp Ther Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1041-1045     Citation Subset:  -    
Affiliation:
Department of Thoracic Surgery, Kitasato University, School of Medicine, Kanagawa, Japan ;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis.
Next Document:  Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcin...